"The future will be more choices, and that's a great thing," Ricks said
Its one of the most reliable ways to access regulated, brand-name treatment at an affordable price
doi: 10.1056/NEJMcp2102062 [DOI] [PubMed] [Google Scholar] 233
The most advanced program, Daewoong Therapeutics' CLOPAM platform, achieved over 80% relative bioavailability for semaglutide versus subcutaneous injection in a 70-person Phase 1 study (August 2025)
More than three quarters of the patients had had a previous myocardial infarction, and nearly one quarter had chronic heart failure
Popular GLP-1 weight-loss drugs linked to lower risks of addiction and overdose Popular weight-loss drugs may also help silence the cravings behind addiction, reducing risks across alcohol, nicotine, opioids, and other substances